Online first
Review paper
Published online: 2024-09-18
Association between MMP-9-C1562Tpolymorphism and susceptibility to preeclampsia: a systematic review and meta-analysis
DOI: 10.5603/gpl.100274
Pubmed: 39411825
Abstract
Objectives: This meta-analysis aims to explore the association between MMP-9-C1562T polymorphism and susceptibility to preeclampsia (PE). Material and methods: Four English databases were searched to collect relevant records up to April 2024. The pooled odds ratio (OR) was calculated using Stata 15.0. Results: A total of 10 studies were enrolled in our systematic review. The results showed that genotype CT at MMP-9-C1562T locus increased the risk of PE versus genotype TT (Genotype CT vs TT: OR = 2.32, 95% CI: 1.27–4.24, P = 0.006), but no significant differences were found in other gene models (C vs T: OR = 0.88, 95% CI: 0.71–1.08, P = 0.225; Genotype CC vs TT: OR = 1.51, 95% CI: 0.87–2.61, P = 0.139; Genotype CC + CT vs TT: OR = 1.63, 95% CI: 0.95-2.81, P = 0.079; Genotype CC vs CT + TT: OR = 0.80, 95% CI: 0.63–1.03, P = 0.086). Subgroup analysis by ethnicity showed a statistically significant difference in the heterozygous model in China (Genotype CT vs TT: OR = 2.38, 95% CI: 1.15 –4.91, P = 0.019). Conclusions: Association of MMP-9-C1562T polymorphism with susceptibility to PE exists. Specifically, genotype CT increases the risk of PE versus genotype TT, particularly in Caucasian populations.
Keywords: MMP-9polymorphismsusceptibilitymeta-analysis
References
- Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335(7627): 974.
- Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013; 170(1): 1–7.
- Huang X, Li Z, Lei J, et al. Genetic polymorphism in DGCR8 is associated with late onset of preeclampsia. BMC Med Genet. 2019; 20(1): 151.
- Zheng Y, Ma C, Liu X, et al. Association between HLA-A gene polymorphism and early-onset preeclampsia in Chinese pregnant women early-onset. BMC Pregnancy Childbirth. 2020; 20(1): 656.
- Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells. 2020; 9(5).
- Mehana ESE, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci. 2019; 234: 116786.
- Yang H, Chen H, Liu F, et al. Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin. BMC Nephrol. 2021; 22(1): 211.
- Narayanan K, Kumar S, Padmanabhan P, et al. Lineage-specific exosomes could override extracellular matrix mediated human mesenchymal stem cell differentiation. Biomaterials. 2018; 182: 312–322.
- Vandooren J, Van Damme Jo, Opdenakker G. On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation. Prog Brain Res. 2014; 214: 193–206.
- Etesami E, Nikukar H, Ramezanali F, et al. Gene expression analysis of MMPs in women with preeclampsia using cell-free fetal RNA in maternal plasma. Pregnancy Hypertens. 2019; 17: 261–268.
- Gannoun MB, Raguema N, Zitouni H, et al. MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study. J Clin Med. 2021; 10(12).
- Sakowicz A, Lisowska M, Biesiada L, et al. Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (, , , and ) Genes with Preeclampsia. Dis Markers. 2018; 2018: 1371425.
- Sun C, Zhang Q, Hu B, et al. Investigation of the association between matrix metalloproteinase-9 genetic polymorphisms and development of pre-eclampsia in Chinese pregnant women. Genet Mol Res. 2016; 15(3).
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009; 3(3): e123–e130.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603–605.
- Peng L, Jin S, Lu J, et al. Association between growth differentiation factor 5 rs143383 genetic polymorphism and the risk of knee osteoarthritis among Caucasian but not Asian: a meta-analysis. Arthritis Res Ther. 2020; 22(1): 215.
- Zhou JF, Luo JY, Zhu WB, et al. Association between genetic polymorphism of heme oxygenase 1 promoter and neonatal hyperbilirubinemia: a meta-analysis. J Matern Fetal Neonatal Med. 2021; 34(1): 12–23.
- Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11): 1539–1558.
- Rahimi Z, Rahimi Z, Shahsavandi MO, et al. MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomark Med. 2013; 7(1): 93–98.
- Leonardo DP, Albuquerque DM, Lanaro C, et al. Association of Nitric Oxide Synthase and Matrix Metalloprotease Single Nucleotide Polymorphisms with Preeclampsia and Its Complications. PLoS One. 2015; 10(8): e0136693.
- Coolman M, de Maat M, Van Heerde WL, et al. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta. 2007; 28(7): 709–713.
- Fraser R, Walker JJ, Ekbote UV, et al. Interleukin‐4 −590 (C>T), toll‐like receptor‐2 +2258 (G>A) and matrix metalloproteinase‐9 −1562 (C>T) polymorphisms in pre‐eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology. 2008; 115(8): 1052–1056.
- Palei ACT, Sandrim VC, Duarte G, et al. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin Chim Acta. 2010; 411(11-12): 874–877.
- Luizon MR, Sandrim VC, Palei ACt, et al. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy. Hypertens Res. 2012; 35(9): 917–921.
- Palei ACT, Sandrim VC, Amaral LM, et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J. 2012; 12(6): 489–498.
- Orlovic M, Tomic V, Vukojevic K, et al. Decreased expression of MMP-9 in CD8 cells in placenta with severe preeclampsia. Biotech Histochem. 2017; 92(4): 288–296.
- Sahay AS, Jadhav AT, Sundrani DP, et al. Matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases -9 (MMP-9) are differentially expressed in different regions of normal and preeclampsia placentae. J Cell Biochem. 2018; 119(8): 6657–6664.
- Abbasi H, Dastgheib SA, Hadadan A, et al. Association of Endothelial Nitric Oxide Synthase 894G > T Polymorphism with Preeclampsia Risk: A Systematic Review and Meta-Analysis based on 35 Studies. Fetal Pediatr Pathol. 2021; 40(5): 455–470.
- Gong LL, Liu He, Liu LH. Lack of association between matrix metalloproteinase-9 gene-1562C/T polymorphism and preeclampsia: a meta-analysis. Hypertens Pregnancy. 2014; 33(4): 389–394.
